Abstract: An example electronic device includes a display; a communication circuit; a memory storing one or instructions; and a processor for executing the one or more instructions to configure the processor to control the electronic device to: display, on the display, a message compose screen; receive message compose inputs to the message compose screen for composing a message; receive a message send input for sending the message via the communication circuit; set a timer; and send the message, via the communication circuit, after expiration of the timer.

Abstract: An energy storage device comprises a capacitor having a dielectric between opposite electrodes and a nonconductive coating between at least one electrode and the dielectric. The nonconductive coating allows for much higher voltages to be employed than in traditional EDLCs, which significantly increases energy stored in the capacitor. Viscosity of the dielectric material may be increased or decreased in a controlled manner, such as in response to an applied external stimulus, to control discharge and storage for extended periods of time.

Abstract: An energy storage device comprises a capacitor having a dielectric between opposite electrodes and a nonconductive coating between at least one electrode and the dielectric. The nonconductive coating allows for much higher voltages to be employed than in traditional EDLCs, which significantly increases energy stored in the capacitor. Viscosity of the dielectric material may be increased or decreased in a controlled manner, such as in response to an applied external stimulus, to control discharge and storage for extended periods of time.

Abstract: A method is provided for making a high permittivity dielectric material for use in capacitors. Several high permittivity materials in an organic nonconductive media with enhanced properties and methods for making the same are disclosed. A general method for the formation of thin films of some particular dielectric material is disclosed, wherein the use of organic polymers, shellac, silicone oil, and/or zein formulations are utilized to produce low conductivity dielectric coatings. Additionally, a method whereby the formation of certain transition metal salts as salt or oxide matrices is demonstrated at low temperatures utilizing mild reducing agents. Further, a circuit structure and associated method of operation for the recovery and regeneration of the leakage current from the long-term storage capacitors is provided in order to enhance the manufacturing yield and utility performance of such devices.

Abstract: A method of maintaining aircraft provides for the secure, efficient acquisition and certification of aircraft parts as a closed loop system within the airfield where the aircraft is grounded and in proximity to the aircraft.

Abstract: Methods are disclosed for creating extremely high permittivity dielectric materials for use in capacitors and energy storage devices. High permittivity materials suspended in an organic non-conductive media matrix with enhanced properties and methods for making the same are disclosed. A general method for the formation of thin films of some particular dielectric material is disclosed, wherein the use of organic polymers, shellac, silicone oil, and/or zein formulations are utilized to produce thin film low conductivity dielectric coatings. Additionally, methods whereby the formation of certain transition metal salts as salt or oxide matrices at low temperatures utilizing mild reducing agents are disclosed. Further, a method for the enhancement of dielectric permittivity formation in the dielectric material of the capacitor is taught.

Abstract: An enhanced playback method including receiving real time content from source links connected to a sources, simultaneously storing the real time content as stored content using a fault tolerant and load balancing method, aggregating the real time content and stored content from additional content, delivering content real time or stored in response to a user request from a user on a terminal system using a cut-through forwarding method. A content/service handling and delivery system including source input/output (I/O) links, a content handling subsystem, the content handling subsystem connected to the source input links, a service delivery subsystem connected to the content handling subsystem, an input and interaction subsystem connected to the service delivery subsystem and terminal I/O links, the plurality terminal I/O links connected to the service delivery subsystem.

Abstract: A method of maintaining aircraft provides for the secure, efficient acquisition and certification of aircraft parts as a closed loop system within the airfield where the aircraft is grounded and in proximity to the aircraft.

Abstract: The present invention generally relates to the determination of photoluminescence of samples. More specifically, the present invention is directed to a method particularly adapted to samples which are flowing liquids. The method and apparatus are useful for measuring photoluminescing species such as those found in liquid chromatography and capillary electrophoresis.

Abstract: An apparatus for measuring spectral absorbance using unique optical modulator capable of temporally changing the spectral wavelength proportion of the light source to produce spectral absorbance data of a sample having: a) a light source able to produce light in the desired wavelength region to be measured for spectral absorbance. b) optical modulator capable of temporally changing the spectral wavelength proportion of the light source. c) sample holder capable of introducing the sample into the light path and d) photosensor for determining the total light intensity after passing through the sample.

Abstract: A first entity maintains an inventory of advertising opportunities in content and services. At least some of the advertising opportunities are bound with advertising on behalf of a second entity that is separate from the first entity.

Abstract: A pharmaceutical formulation of paclitaxel and polyethoxylated castor oil is disclosed to be relatively acidified to a pH of less than 8.1 and preferably within a pH range of 5 to 7, inclusively. Ethanol is optionally included in the formulation which is adapted for use in a body for the treatment of cancer. A formulation method is disclosed and includes the step of mixing an acid with a carrier material, such as polyethoxylated castor oil, to form a carrier solution after which paclitaxel is added in an amount such that the resulting pH is less than 8.1 and preferably in a pH range of 5 to 7. Ethanol may optionally be slurried with the paclitaxel before mixing with the carrier solution. A variety of acidifying agents, a preferred one being anhydrous citric acid, are described.

Abstract: A pharmaceutical formulation of paclitaxel and polyethoxylated castor oil is disclosed to be relatively acidified to a pH of less than 8.1 and preferably within a pH range of 5 to 7, inclusively. Ethanol is optionally included in the formulation which is adapted for use in a body for the treatment of cancer, A formulation method is disclosed and includes the step of mixing an acid with a carrier material, such as polyethoxylated castor oil, to form a carrier solution after which paclitaxel is added in an amount such that the resulting pH is less than 8.1 and preferably in a pH range of 5 to 7. Ethanol may optionally be slurried with the paclitaxel before mixing with the carrier solution. A variety of acidifying agents, a preferred one being anhydrous citric acid, are described.

Abstract: An enhanced playback method including receiving real time content from source links connected to a sources, simultaneously storing the real time content as stored content using a fault tolerant and load balancing method, aggregating the real time content and stored content from additional content, delivering content real time or stored in response to a user request from a user on a terminal system using a cut-through forwarding method.

Abstract: A method for assembling multimedia streams enables assembly of any of a number of possible output multimedia streams from segments of source multimedia streams. Enabling assembly of the streams includes computing stream fragments for insertion between successive of the segments to form any of the output streams. According to such a method, computation required for creating transition points in source MPEG streams can be largely performed as a preprocess that produces data that can be stored for use in later assembling a stream, assembly of a stream requires relatively little computation and can be implemented using relatively inexpensive equipment, for example, in software.

Abstract: A pharmaceutical formulation of paclitaxel and polyethoxylated castor oil is disclosed to be relatively acidified to a pH of than 8.1 and preferably within a pH range of 5 to 7, inclusively. Ethanol is optionally included in the formulation which is adapted for use in a body for the treatment of cancer, A formulation method is disclosed and includes the step of mixing an acid with a carrier material, such as polyethoxylated castor oil, to form a carrier solution after which paclitaxel is added in an amount such that the resulting pH is less than 8.1 and preferably in a pH range of 5 to 7. Ethanol may optionally be slurried with the paclitaxel before mixing with the carrier solution. A variety of acidifying agents, a preferred one being anhydrous citric acid, are described.

Abstract: A pharmaceutical formulation of paclitaxel and polyethoxylated castor oil is disclosed to be relatively acidified to a pH of less than 8.1 and preferably within a pH range of 5 to 7, inclusively. Ethanol is optionally included in the formulation which is adapted for use in a body for the treatment of cancer. A formulation method is disclosed and includes the step of mixing an acid with a carrier material, such as polyethoxylated castor oil, to form a carrier solution after which paclitaxel is added in an amount such that the resulting pH is less than 8.1 and preferably in a pH range of 5 to 7. Ethanol may optionally be slurried with the paclitaxel before mixing with the carrier solution. A variety of acidifying agents, a preferred one being anhydrous citric acid, are described.

Abstract: A pharmaceutical formulation of paclitaxel (also known as taxol) and polyethoxylated castor oil is disclosed to be relatively acidified to a pH of less than 8.1 and preferably within a pH range of 5 to 7, inclusively. Ethanol is optionally included in the formulation which is adapted for use in a body for the treatment of cancer. A formulation method is disclosed and includes the step of mixing an acid with a carrier material, such as polyethoxylated castor oil, to form a carrier solution after which taxol is added in an amount such that the resulting pH is less than 8.1 and preferably in a pH range of 5 to 7. Ethanol may optionally be slurried with the paclitaxel before mixing with the carrier solution. A variety of acidifying agents, a preferred one being anhydrous citric acid, are described.

Abstract: A pharmaceutical formulation of taxol and polyethoxylated castor oil is disclosed to be relatively acidified to pH of less 8.1 and preferably within a pH range of 5 to 7, inclusively, by an acidifying agent. Ethanol is optionally included in the formulation which is adapted for use in a body for the treatment cancer. A formulation method is disclosed and includes the step of mixing an acid with a carrier material, such as polyethoxylated castor oil, to form a carrier solution after which taxol is added in an amount such that the resulting pH is less than 8.1 and preferably in a pH range of 5 to 7. Ethanol may optionally be slurried with the taxol before mixing with the carrier solution. A variety of acidifying agents, a preferred one being anhydrous citric acid, are described.

Abstract: A pharmaceutical formulation of taxol and polyethoxylated castor oil is disclosed to be stabilized by reducing its pH to less than 8.1 and preferably within a pH range of 5 to 7, inclusively. Ethanol is optionally included in the formulation which is adapted for use in a body for the treatment of cancer. A formulation method is disclosed and includes the step of reducing the pH of a carrier material, such as polyethoxylated castor oil, to form a carrier solution after which taxol is added in an amount such that the resulting pH is less than 8.1 and preferably in a pH range of 5 to 7. Ethanol may optionally be slurried with the taxol before mixing with the carrier solution.